Moreover, a vast number of anti-tumor drugs including docetaxel [42], doxorubicin (DOX) [43], mitogen-activated protein kinases 1/2 (MEK1/2) inhibitors [44], and pabisterostat [45] have been demonstrated to have anti-cancer activity in human cancer and links to CQ. This evidence concerns the gene MAP2K1 and neoplasm.